Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer
Authors:
- 16 August 2014
- journal article
- Published by Springer Nature in Virchows Archiv
- Vol. 465 (4) , 463-471
Abstract
MicroRNAs (miRNAs) are short non-coding RNAs that exert a critical influence on tumorigenesis through post-transcriptional modification and are considered to be potential biomarkers for the diagnosis or prognosis of various cancers. Although several miRNAs have been proposed as relevant biomarkers for non-small cell lung cancer (NSCLC), detailed working mechanisms and validated prognostic significance of these miRNAs remain controversial. In this study, we evaluated expression levels of miRNA-126 (miR-126) and miR-200c in 72 NSCLCs and 30 benign lung tissues by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and analyzed the correlation of miRNA expression with a variety of clinicopathological factors and patient survival. Compared with the benign control group, miR-126 expression was significantly downregulated in NSCLCs (p < 0.001), while miR-200c expression was significantly upregulated in NSCLCs (p < 0.001). The expression of miR-126 was significantly higher in NSCLCs with a tumor size of ≤3 cm than in those with a tumor size of >3 cm (p = 0.026). There were no other significant associations between miRNA expression and clinicopathological features. In univariate survival analysis for all NSCLC patients, high miR-200c expression (p = 0.037), large tumor size (p = 0.026), and lymphovascular invasion (p = 0.012) were significantly correlated with worse overall survival. High miR-126 expression was significantly associated with favorable prognosis only in patients with adenocarcinoma (p = 0.033). In multivariate analysis, miR-200c and tumor size remained as independent prognostic factors. Our results suggest that miR-126 might play tumor-suppressive and miR-200c an oncogenic role, and these miR’s are potential prognostic biomarkers for NSCLC.Keywords
This publication has 33 references indexed in Scilit:
- The proto-oncogene KRAS is targeted by miR-200cOncotarget, 2013
- Meta‐analysis of microRNA expression in lung cancerInternational Journal of Cancer, 2012
- let-7b and miR-126 Are Down-Regulated in Tumor Tissue and Correlate with Microvessel Density and Survival Outcomes in Non–Small–Cell Lung CancerPLOS ONE, 2012
- Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling PathwayClinical Cancer Research, 2011
- Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancerCancer, 2011
- Staging of non-small cell lung cancer (NSCLC): A reviewRespiratory Medicine, 2010
- MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell linesBiochemical and Biophysical Research Communications, 2008
- MicroRNA—implications for cancerVirchows Archiv, 2007
- The role of epithelial-mesenchymal transition in cancer pathologyPathology, 2007
- Unique microRNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell, 2006